The planned factory in Upper Macungie Township gives Pennsylvania a big win in the race to attract some of the billions in spending by Big Pharma to boost U.S. manufacturing.

The agreement will raise THAAD interceptor production from 96 to 400 units.

The plant will help make Lilly's experimental drug called retatrutide, which has shown the highest weight loss seen to date in a late-stage trial.

For the things that can’t be safely self-served, don’t default to custom builds. Create simple, reusable tools that non-IT teams can use to fulfill their needs without opening a ticket. Self-service ...

As climate change extends mosquito habitats and vector-borne diseases remain a critical concern, industry analysis suggests ...

As supply chain vulnerabilities intensify and competition accelerates, the cost of this underutilization could risk India's competitive position.

ALVARADO, TX, UNITED STATES, January 13, 2026 /EINPresswire.com/ -- Shannon Carver is a seasoned leadership consultant, ...

DAVIS, Calif., Jan. 28, 2026 /PRNewswire/ -- Symmetry Laser, a leading provider of precision laser cutting solutions for the medical device industry, today announced the completion of its acquisition ...

ASML Holding's management says demand tied to artificial intelligence is proving more durable than previously expected, with ...

Operating from two northern Ohio facilities totaling more than 130,000 sq. ft., Vicon Fabricating Co. is built for ...

The Trump administration signed a notable multibillion-dollar trade deal with Taiwan that’s designed to help the United States boost domestic semiconductor manufacturing. Under the deal announced by ...

PHILADELPHIA, MS, UNITED STATES, January 7, 2026 /EINPresswire.com/ — As poultry consumption continues to rise across the United States, production systems ...